MedPath

Ferring Pharmaceuticals, Inc.

🇺🇸United States
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.ferringusa.com

A Clinical Study to Evaluate the Pharmacokinetics of Testosterone Gel Using an Applicator

Phase 2
Completed
Conditions
Hypogonadal Males
Interventions
First Posted Date
2011-11-04
Last Posted Date
2017-09-13
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
20
Registration Number
NCT01464879
Locations
🇺🇸

AccuMed Research Associates, Garden City, New York, United States

A Dose-response Trial Using rFSH FE 999049 in Women Undergoing IVF/ICSI Treatment

Phase 2
Completed
Conditions
Infertility
Interventions
Drug: Gonal - F
First Posted Date
2011-08-31
Last Posted Date
2020-11-17
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
265
Registration Number
NCT01426386
Locations
🇧🇪

UZ Gent, Gent, Belgium

🇨🇿

ICF CUBE, Prague, Czechia

🇪🇸

IVI Sevilla, Sevilla, Spain

and more 5 locations

Menopur Mixed Protocol

Phase 4
Completed
Conditions
Infertility
Interventions
Drug: Bravelle
First Posted Date
2011-08-16
Last Posted Date
2014-05-16
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
122
Registration Number
NCT01417195
Locations
🇺🇸

Houston Fertility Institute, Houston, Texas, United States

🇺🇸

The Center for Assisted Reproduction, Bedford, Texas, United States

🇺🇸

Women's Medical Research Group, Clearwater, Florida, United States

and more 7 locations

Prospective, Longitudinal Multicentric Survey in the Therapeutic Care of Mild to Moderate Ulcerative Colitis

Completed
Conditions
Ulcerative Colitis
First Posted Date
2011-07-04
Last Posted Date
2015-10-29
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
812
Registration Number
NCT01387698
Locations
🇫🇷

Cabinet Médicale, Quevert, France

🇫🇷

Centre Hospitalier pays d aix, Aix en Provence Cedex 1, France

🇫🇷

Clinique Saint Joseph, Angers, France

and more 77 locations

A Study of Terlipressin in Patients With Hepatorenal Syndrome Type 1

Phase 1
Completed
Conditions
Hepatorenal Syndrome Type 1
Interventions
First Posted Date
2011-06-15
Last Posted Date
2012-02-14
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
8
Registration Number
NCT01373606
Locations
🇯🇵

Investigational site, Kanto, Japan

Efficacy, Pharmacokinetics and Safety of Testosterone

Phase 2
Completed
Conditions
Testicular Hypogonadism
Interventions
First Posted Date
2011-06-09
Last Posted Date
2017-09-13
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
20
Registration Number
NCT01370369
Locations
🇺🇸

AccuMed Research Associates, Garden City, New York, United States

MINRIN® Orally Disintegrating Tablet (Fast Dissolving Desmopressin) and Tablets in Treatment of Primary Nocturnal Enuresis

Completed
Conditions
Nocturnal Enuresis
First Posted Date
2011-06-08
Last Posted Date
2013-06-12
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
138
Registration Number
NCT01368913
Locations
🇩🇪

Investigational Site, Mahlsdorfer Straße 39-40, Berlin, Germany

🇩🇪

Investigational Site, Neckarstrasse 7, Berlin, Germany

🇩🇪

Investigational Site, Westfalenstraße 26, Düsseldorf, Germany

and more 10 locations

Online Surveillance of Treatment of Children With Growth Hormone Deficiency With ZOMACTON

Completed
Conditions
Growth Hormone Deficiency
Interventions
Other: Growth hormone
First Posted Date
2011-06-03
Last Posted Date
2017-06-02
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
1034
Registration Number
NCT01365351
Locations
🇩🇪

Investigational Site, Dr.-Friedrich-Steiner-Straße 5, Datteln, Germany

🇩🇪

Investigational Site, Alexandrinenstraße 5, Bochum, Germany

🇩🇪

Investigational Site, Fetscherstraße 74, Dresden, Germany

and more 44 locations

Retrospective Data Analysis in Crohn's Disease

Completed
Conditions
Crohn's Disease
First Posted Date
2011-06-01
Last Posted Date
2011-06-01
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
161
Registration Number
NCT01363427
Locations
🇩🇪

Investigational Site, Ehrenfelsstraße 47, Berlin, Germany

🇩🇪

Investigational Site, Am Tiefen Weg 2, Karlstadt, Germany

🇩🇪

Investigational Site, Münchner Straße 64, Dachau, Germany

and more 13 locations

User Surveillance in Ulcerative Colitis

Completed
Conditions
Ulcerative Colitis
First Posted Date
2011-06-01
Last Posted Date
2011-06-01
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
500
Registration Number
NCT01363453
Locations
🇩🇪

Investigational Site, Hans-Böckler-Straße 20, Dinslaken, Germany

🇩🇪

Investigational Site, Münsterstraße 18, Bonn, Germany

🇩🇪

Investigational Site, Viktoriastraße 5, Euskirchen, Germany

and more 102 locations
© Copyright 2025. All Rights Reserved by MedPath